PetMed Express (PETS) Expected to Announce Quarterly Earnings on Thursday

PetMed Express (NASDAQ:PETS) will likely be announcing its earnings results before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings of ($0.01) per share and revenue of $59.60 million for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

PetMed Express (NASDAQ:PETS) last posted its earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.17. The business had revenue of $59.57 million for the quarter, compared to analysts’ expectations of $66.02 million. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. On average, analysts expect PetMed Express to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

PetMed Express Trading Up 2.1 %

NASDAQ PETS opened at $4.91 on Wednesday. PetMed Express has a 1-year low of $2.90 and a 1-year high of $6.85. The company has a market capitalization of $101.44 million, a price-to-earnings ratio of -81.83 and a beta of 0.70. The stock’s 50 day moving average is $5.09 and its two-hundred day moving average is $4.28.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded PetMed Express from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th.

Insider Transactions at PetMed Express

In other PetMed Express news, Director Leslie C.G. Campbell bought 15,000 shares of the stock in a transaction dated Wednesday, December 4th. The stock was bought at an average cost of $5.38 per share, for a total transaction of $80,700.00. Following the completion of the purchase, the director now owns 70,000 shares in the company, valued at $376,600. This represents a 27.27 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.10% of the company’s stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.